Slowing progression and preventing complications of chronic kidney disease
Home | Video pages | Webcast | The role of complement in glomerulonephritis: are novel therapies ready for prime time?
Seleccione su idioma favorito
Slowing progression and preventing complications of chronic kidney disease
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Los contenidos traducidos en esta página son resultado de una traducción automática.
Algunos contenidos no están traducidos (ej. normativa, pdfs, publicaciones).